Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.01) by 800 percent. This is a 600 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $126.66 million which beat the analyst consensus estimate of $109.60 million by 15.56 percent. This is a 27.10 percent increase over sales of $99.65 million the same period last year.